These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 37672130)

  • 1. Does Renal Denervation a Reasonable Treatment Option in Hemodialysis-Dependent Patient with Resistant Hypertension? A Narrative Review.
    Mazza A; Dell'Avvocata F; Torin G; Bulighin F; Battaglia Y; Fiorini F
    Curr Hypertens Rep; 2023 Nov; 25(11):353-363. PubMed ID: 37672130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Catheter-based renal denervation in Chinese patients with chronic kidney disease and uncontrolled hypertension.
    Liu S; Bian R; Qian Y; Liao H; Gao X; Zhang Y; Dong W
    J Clin Hypertens (Greenwich); 2023 Jan; 25(1):71-77. PubMed ID: 36478498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal Innervation in Resistant Hypertension: A Review of Pathophysiology and Renal Denervation as Potential Treatment.
    Wilson AL; Gandhi J; Suh Y; Joshi G; Smith NL; Khan SA
    Curr Hypertens Rev; 2020; 16(2):115-127. PubMed ID: 30827252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on Renal Sympathetic Denervation for the Treatment of Hypertension.
    Rao A; Krishnan N
    Curr Cardiol Rep; 2022 Oct; 24(10):1261-1271. PubMed ID: 35895182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years.
    Ott C; Mahfoud F; Mancia G; Narkiewicz K; Ruilope LM; Fahy M; Schlaich MP; Böhm M; Schmieder RE
    Nephrol Dial Transplant; 2022 Jan; 37(2):304-310. PubMed ID: 34109413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C; Mahfoud F; Schmid A; Toennes SW; Ewen S; Ditting T; Veelken R; Ukena C; Uder M; Böhm M; Schmieder RE
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Individual-patient visit-by-visit office and ambulatory blood pressure measurements over 24months in patients undergoing renal denervation for hypertension.
    Lambert T; Gammer V; Nahler A; Blessberger H; Kammler J; Grund M; Kerschner K; Buchmayr G; Saleh K; Kypta A; Hönig S; Wichert-Schmitt B; Schwarz S; Sihorsch K; Reiter C; Steinwender C
    Int J Cardiol; 2015 Feb; 181():96-101. PubMed ID: 25497527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year follow-up of very-high risk hypertensive patients undergoing renal sympathetic denervation.
    Wang L; Li C; Li Z; Li Q; Liu C; Sun X; He Q; Xia DS; Xia D; Lu C
    J Hypertens; 2024 May; 42(5):801-808. PubMed ID: 38164953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal Denervation in Isolated Systolic Hypertension Using Different Catheter Techniques and Technologies.
    Fengler K; Rommel KP; Lapusca R; Blazek S; Besler C; Hartung P; von Roeder M; Kresoja KP; Desch S; Thiele H; Lurz P
    Hypertension; 2019 Aug; 74(2):341-348. PubMed ID: 31203726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of catheter-based renal denervation on cardiac sympathetic activity and innervation in patients with resistant hypertension.
    Donazzan L; Mahfoud F; Ewen S; Ukena C; Cremers B; Kirsch CM; Hellwig D; Eweiwi T; Ezziddin S; Esler M; Böhm M
    Clin Res Cardiol; 2016 Apr; 105(4):364-71. PubMed ID: 26493305
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catheter-Based Renal Denervation: 9-Year Follow-Up Data on Safety and Blood Pressure Reduction in Patients With Resistant Hypertension.
    Sesa-Ashton G; Nolde JM; Muente I; Carnagarin R; Lee R; Macefield VG; Dawood T; Sata Y; Lambert EA; Lambert GW; Walton A; Kiuchi MG; Esler MD; Schlaich MP
    Hypertension; 2023 Apr; 80(4):811-819. PubMed ID: 36762561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of renal denervation on tissue Na
    Ott C; Kopp C; Dahlmann A; Schmid A; Linz P; Cavallaro A; Hammon M; Ditting T; Veelken R; Uder M; Titze J; Schmieder RE
    Clin Res Cardiol; 2018 Jan; 107(1):42-48. PubMed ID: 28845508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
    Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
    J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal denervation in the management of hypertension in adults. A clinical consensus statement of the ESC Council on Hypertension and the European Association of Percutaneous Cardiovascular Interventions (EAPCI).
    Barbato E; Azizi M; Schmieder RE; Lauder L; Böhm M; Brouwers S; Bruno RM; Dudek D; Kahan T; Kandzari DE; Lüscher TF; Parati G; Pathak A; Ribichini FL; Schlaich MP; Sharp ASP; Sudano I; Volpe M; Tsioufis C; Wijns W; Mahfoud F
    Eur Heart J; 2023 Apr; 44(15):1313-1330. PubMed ID: 36790101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
    Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
    Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.
    Hoogerwaard AF; de Jong MR; Elvan A
    Curr Hypertens Rep; 2018 Mar; 20(3):24. PubMed ID: 29556850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ultrasound-based renal sympathetic denervation for the treatment of therapy-resistant hypertension: a single-center experience.
    Fengler K; Höllriegel R; Okon T; Stiermaier T; Rommel KP; Blazek S; Besler C; von Roeder M; Petzold M; Schuler G; Lurz P
    J Hypertens; 2017 Jun; 35(6):1310-1317. PubMed ID: 28441700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of renal denervation for the treatment of resistant hypertension.
    McLellan AJ; Kistler PM; Walton AS; Schlaich MP
    J Hum Hypertens; 2014 Apr; 28(4):218-23. PubMed ID: 24088716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease.
    Schlaich MP; Bart B; Hering D; Walton A; Marusic P; Mahfoud F; Böhm M; Lambert EA; Krum H; Sobotka PA; Schmieder RE; Ika-Sari C; Eikelis N; Straznicky N; Lambert GW; Esler MD
    Int J Cardiol; 2013 Oct; 168(3):2214-20. PubMed ID: 23453868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The blood pressure-lowering effect of renal denervation is inversely related to kidney function.
    Vink EE; Verloop WL; Bost RB; Voskuil M; Spiering W; Vonken EJ; Bots ML; Blankestijn PJ
    J Hypertens; 2014 Oct; 32(10):2045-53; discussion 2053. PubMed ID: 25023158
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.